Article Details

Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 ...

Retrieved on: 2021-04-11 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 .... View article details on hiswai:

Excerpt

JTX-8064 is a humanized IgG4 monoclonal antibody designed to specifically bind to Leukocyte Immunoglobulin Like Receptor B2 (LILRB2/ILT4) and ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo